CASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion Leader Call On BI-1206 For Relapsed Or Refractory Non-Hodgkin’s Lymphoma 21. Januar 2021 INDIZES WEUR More
Wirtschaft, Handel & Finanzen Aktien Europa Schluss: Anleger begrüßen Machtwechsel in den USA 20. Januar 2021 INDIZES WEUR More
BioInvent to host Key Opinion Leader call on BI-1206 for relapsed or refractory Non-Hodgkin’s Lymphoma 20. Januar 2021 INDIZES WEUR More
NASDAQ OMX Nordic: Derivatives: Updates to LP program for Mini OMXS30 Futures (06/21) 20. Januar 2021 INDIZES WEUR More